In summary, bone metastases of breast, prostate, and lung cancer share a few molecular mechanisms, which are responsible for the AKT activation in the tumor cells and the bone cells, as well as show a similar pattern of downstream effectors of an activated AKT in tumor and bone cells. Here, AKT1 is linked to neoplasm.